Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000921895-20-003080
Filing Date
2020-11-20
Accepted
2020-11-20 19:36:35
Documents
1
Period of Report
2020-11-18

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT form411577002cas_11202020.html 4  
1 OWNERSHIP DOCUMENT form411577002cas_11202020.xml 4 4125
  Complete submission text file 0000921895-20-003080.txt   5702
Mailing Address 9 FISHERS LANE SUITE E SPARTA NJ 07871
Business Address 9 FISHERS LANE SUITE E SPARTA NJ 07871 (713) 842-1249
PLx Pharma Inc. (Issuer) CIK: 0001497504 (see all company filings)

EIN.: 271707962 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 8285 EL RIO STREET SUITE 130 HOUSTON TX 77054
Business Address
Casale Robert (Reporting) CIK: 0001661196 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36351 | Film No.: 201333933